Vaginal Tightening and Rejuvenation


During the course of life, genital organs undergo physiological changes of shape and volume as well as functional changes. In particular, during menopause, tissues surrounding the perineum often atrophy or degrade, reaction to stimulus may decrease, tissues may lose functionality and turgidity and the area may suffer a loss of sensitivity.

Loss of elasticity and strength in vaginal tissue occurs also for a number of reasons, including:

– Aging
– Smoking
– Obesity
– Childbirth
– Hysterectomy
– Surgery

These events replace the skin’s natural collagen with fibers that do not recoil or stretch properly. VagiLift Vaginal tightening with Carboxytherapy is a cosmetic procedure that restores the appearance and function of the vaginal area.

In Cosmetic Medicine it is possible to use Carboxytherapy to obtain a non-surgical vaginal rejuvenation. The role of this therapy is to oxygenate and reactivate the metabolic and draining processes that slow down with physiological ageing with the aim of making the area more turgid and hydrated and giving shape back to lost volumes.

VagilLift  CarboxyTherapy consists of 5 or 6 micro injections of Carbon Dioxide performed in the area, to stimulate the growth of new capillaries in the tissues. It is a quick procedure with no downtime and patients may go back to normal activities immediately after treatment.  The results are: renewed turgidity in the treated area, improved circulation and consequent reactivation of tissue functions and an increase in the quantity of tissue in the area.

Thanks to Carboxytherapy it is possible to improve not only the aesthetic aspect of the treated area, but also the quality of the patients’ sex life, with an increase in orgasmic activity thanks to renewed tissue turgidity, tone and functionality and to improved lubrication.


Miembros del equipo: adrian gaspar


A. Gaspar; H. Brandi.
Gynecology Department, Faculty of Medicine, University of Mendoza, Argentina.

To show our experience in the use of carbonic anhydride (Carboxytherapy) in the treatment of hypotrophy and atrophy of the vaginal mucosa.

We selected two groups of patients (Case and Control). Symptoms of study and treatment: vaginal dryness and dyspareunia. Case group (16 patients, average age 57 years) was treated with vaginal carboxytherapy. Carbonic anhydride is administered two times a week for 12 weeks through a handpiece designed for this purpose. Control group (20 patients, average age 54 years) received topical estrogen therapy with estriol, a daily application of 0.5 mg per day for 2 weeks, and then followed by three times a week for another 2 weeks and finally twice-weekly applications for 4 more weeks.

Monitored by vaginal biopsies and clinical evaluation. There was substantial clinical improvement and significant differences in biopsies before and after treatment in the case group patients compared with the control group patients.

The application of vaginal carboxytherapy in women with signs or symptoms of hypotrophy or atrophy of the vaginal mucosa, showed a marked improvement, not only in the epithelium, but also in the lamina propria, compared with the control group. This is in contrast to the documented effects in the epithelium observed with the use of topical estrogen therapy. We also observed a marked comparative improvement in terms of the sexual discomfort problems reported by the patients.

Sebastiano Accaputo